#COVID-19 treatment

Two scientists cooperating while examining antiviral drug in a test tube at laboratory

FDA Approves Remdesivir for Hospitalized COVID-19 Patients

NIH Study Aims To Identify Promising COVID-19 Treatments for Larger Trials

How is COVID-19 treated?

FDA Approves Remdesivir for Hospitalized COVID-19 Patients

NIH Study Aims To Identify Promising COVID-19 Treatments for Larger...

How is COVID-19 treated?

Immune Modulator Drugs Improved Survival for People Hospitalized With COVID-19

Two drugs widely used to treat certain autoimmune diseases substantially improved clinical status and reduced deaths.

Scientists Identify Characteristics to Better Define Long COVID

Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.

3D model of SARS-CoV2 coronavirus (back) and its spike protein (front) that enables the virus to enter human cells.

Intranasal Proteins Could Protect Against COVID-19 Variants

With further testing, the antiviral proteins might be used as a nasal spray to prevent or treat COVID-19.

FDA Approves First COVID-19 Treatment for Young Children

Remdesivir (Veklury) is now approved for kids ages 28 days to 12 years.

Nasal Antiviral Blocks SARS-CoV-2 Infection in Mice

Antiviral drugs that target host cells may work against many existing and future variants of the virus that causes COVID-19.

How the Test-to-Treat Pillar of the U.S. COVID Strategy Is Failing Patients

Paxlovid and molnupiravir can reduce the risk of severe COVID-19, but they must be started within five days of symptom onset.

Non-English Speakers With COVID-19 Susceptible to Worse Health Outcomes

Racial and ethnic minorities were disproportionately affected by COVID-19 during the first year of the pandemic.

The End of the COVID Emergency Could Mean a Huge Loss of Health Insurance

The United States might see one of the steepest increases in the country’s uninsured rate in years.

Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

To Prevent Future COVID Variants, We Must Protect Those Most At Risk

Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.

The CDC’s New Guidelines on COVID Risk and Masking Send Confounding Signals

The CDC’s move triggered mixed feelings from the public and laid bare a split within the health care community.

FDA OKs Second COVID Antiviral Pill for Limited Use

Molnupiravir is authorized for people at high risk for severe COVID-19 when other treatment options are not available.

FDA Authorizes First Antiviral Pill for COVID-19

Paxlovid, which reduces the risk of hospitalization or death by about 90%, is expected to be a game-changer.

FDA Advisors Recommend Antiviral Pill for Early COVID Treatment

Molnupiravir, the first oral antiviral for COVID-19, reduces the risk of hospitalization or death if started within five days.

Success of COVID Antiviral Pills Hinges on Access to Speedy and Accurate Tests

The new drugs must be used within a narrow window of time after developing symptoms.

Oral Antiviral Drug Cuts COVID-19 Hospitalization [UPDATED]

Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.

Oral Antiviral Cuts COVID-19 Hospitalization by Nearly 90%

Paxlovid dramatically reduced the risk of severe illness and death, but it must be started soon after developing symptoms.

#COVID-19 treatment

FDA Approves Remdesivir for Hospitalized COVID-19 Patients

NIH Study Aims To Identify Promising COVID-19 Treatments for Larger Trials

How is COVID-19 treated?

FDA Approves Remdesivir for Hospitalized COVID-19 Patients

NIH Study Aims To Identify Promising COVID-19 Treatments for Larger...

How is COVID-19 treated?

Immune Modulator Drugs Improved Survival for People Hospitalized With COVID-19

Scientists Identify Characteristics to Better Define Long COVID

Intranasal Proteins Could Protect Against COVID-19 Variants

FDA Approves First COVID-19 Treatment for Young Children

Nasal Antiviral Blocks SARS-CoV-2 Infection in Mice

How the Test-to-Treat Pillar of the U.S. COVID Strategy Is Failing Patients

Non-English Speakers With COVID-19 Susceptible to Worse Health Outcomes

The End of the COVID Emergency Could Mean a Huge Loss of Health Insurance

To Prevent Future COVID Variants, We Must Protect Those Most At Risk

The CDC’s New Guidelines on COVID Risk and Masking Send Confounding Signals

FDA OKs Second COVID Antiviral Pill for Limited Use

FDA Authorizes First Antiviral Pill for COVID-19

FDA Advisors Recommend Antiviral Pill for Early COVID Treatment

Success of COVID Antiviral Pills Hinges on Access to Speedy and Accurate Tests

Oral Antiviral Drug Cuts COVID-19 Hospitalization [UPDATED]

Oral Antiviral Cuts COVID-19 Hospitalization by Nearly 90%

Ask COVID Health

Features